SCHEMBL3901062

SCHEMBL3901062

CCc1ccc(C(=O)N2CCCCC2)c(N)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
L3MBTL3 Q96JM7 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
RAB9A P51151 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 2/20 0.48
CCKBR P32239 1/20 0.45
PKM P14618 1/20 0.44
MEN1 O00255 2/20 0.43
HPGD P15428 6/20 0.43
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ACACB O00763 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3902950 0.89 RAB9A (0.51) POLBL3MBTL3L3MBTL1RAB9AKMT2A
SCHEMBL3901059 0.84 POLB (0.54) POLBL3MBTL1RAB9AKMT2ANPC1
SCHEMBL5913658 0.83 L3MBTL1 (0.49) POLBL3MBTL3L3MBTL1RAB9AKMT2A
SCHEMBL3897143 0.82 HPGD (0.49) POLBL3MBTL3L3MBTL1RAB9AKMT2A
SCHEMBL9971001 0.81 CPS1 (0.56) POLBRAB9AKMT2ANPC1HPGD
SCHEMBL7903535 0.80 POLB (0.55) POLBL3MBTL1RAB9AKMT2ANPC1
SCHEMBL3895787 0.80 HPGD (0.54) L3MBTL3L3MBTL1RAB9AKMT2ANPC1
SCHEMBL24746174 0.80 HPGD (0.64) POLBL3MBTL1KMT2AMEN1HPGD
SCHEMBL3899784 0.80 L3MBTL3 (0.54) POLBL3MBTL3L3MBTL1KMT2ACCKBR
SCHEMBL11919305 0.79 TSHR (0.56) POLBRAB9AKMT2ANPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US claimed
US-7550492-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2009-06-23 US disclosed
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-29 US disclosed
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US disclosed
CN-1829704-A Benzo [1,2,5] thiadiazole compounds as CCK2 modulators JANSSEN PHARMACEUTICA NV (BE) 2006-09-06 CN disclosed
EP-1675837-A2 BENZO [1,2,5] THIADIAZOLE COMPOUNDS AS CCK2 MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-07-05 EP disclosed
WO-2005012275-A2 BENZO [1, 2, 5] THIADIAZOLE COMPOUNDS AS CCK2 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-02-10 WO disclosed
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA, N.V. (BE) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS CCKBR, CCKAR, GIPR POLB 4576/4885L3MBTL3 1603/4885L3MBTL1 1202/4885
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds CCKBR, CCKAR, BRSK2 POLB 4671/4885L3MBTL3 1927/4885L3MBTL1 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.